Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Vascular and molecular pharmacology of the metabolically stable CGRP analogue, SAX

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Gasotransmitters and the immune system: Mode of action and novel therapeutic targets

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. ApoB and apoM - New aspects of lipoprotein biology in uremia-induced atherosclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Does inflammation have a role in migraine?

    Research output: Contribution to journalReviewResearchpeer-review

  4. The changing faces of migraine

    Research output: Contribution to journalEditorialResearchpeer-review

View graph of relations

The main purpose of this study was to compare in vitro pharmacological properties of human αCGRP (CGRP) and a recently discovered metabolically stable CGRP analogue, SAX, in isolated rat and human artery segments. In rat, CGRP and SAX induced similar vasodilatory responses in isolated mesenteric artery with the potency of SAX being lower than that of CGRP (vasodilatory pEC50 8.2 ± 0.12 and 9.0 ± 0.11, respectively). A corresponding difference in receptor binding affinity of SAX and CGRP was determined in rat cerebral membranes (pKi 8.3 ± 0.19 and 9.3 ± 0.14, respectively). CGRP and SAX-induced vasodilation was antagonised with similar potencies by the CGRP receptor antagonist BIBN4096BS supporting a uniform receptor population for the agonists. In human tissue, SAX and CGRP induced similar pharmacological responses with different potencies in subcutaneous artery (vasodilatory pEC50 8.8 ± 0.18 and 9.5 ± 0.13, respectively) and human recombinant receptors (cAMP signalling pEC50 9.1 ± 0.16 and 10.2 ± 0.19). Like in the rat mesenteric artery, both SAX and CGRP-responses were inhibited by the CGRP receptor antagonist BIBN4096BS with similar antagonistic potencies. In conclusion, all pharmacological characteristics of SAX and CGRP in human and rat sources points towards action via a uniform BIBN4096BS sensitive receptor population with the potency of SAX being 5-10 fold lower than that of CGRP.

Original languageEnglish
JournalEuropean Journal of Pharmacology
Volume829
Pages (from-to)85-92
Number of pages8
ISSN0014-2999
DOIs
Publication statusPublished - 2018

    Research areas

  • Journal Article

ID: 53670447